logo
episode-header-image
Apr 2021
1h 22m

Ep. 3: “Platelets and the Immune System”...

The Immunology Podcast
About this episode

Guest:

Dr. Bernardo Franklin is a Professor at the University of Bonn. His lab studies the role of innate immunity in sterile inflammation and in infectious diseases. More recently, their research has focused on blood platelets and their effects on innate immunity, systemic inflammation and cancer.

Featured Products and Resources:

The Immunology Science Round Up

T Cell Mediated Cross-Reactivity between Seasonal Coronaviruses and SARS-CoV-2 – Researchers found that CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.

COVID-19 Recovered Individuals May Only Require a Single mRNA Vaccine Dose – In individuals who have already recovered from COVID-19, a single mRNA vaccine dose was sufficient to achieve peak antibody and memory B cell responses.

Forcing Cancer Out of “Stealth Mode” – DNA methyl transferase inhibitors alter the surface proteome and mediate cytoskeletal reorganization, priming γδ T cells to kill lung cancer cells.

Maternal Treg Cells Can Reverse Behavioral Abnormalities in Adult Mouse Offspring  – Behavioral abnormalities caused by maternal immune activation could be rescued by transferring pathogen-activated maternal Treg cells.

Photo Reference: Courtesy of Dr. Bernardo Franklin

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe
Up next
Oct 7
Ep. 116: “Allelic Variation” Featuring Dr. Robin Orozco
Dr. Robin Orozco is an Assistant Professor at the University of Kansas, where her lab studies how specific allelic variants affect immune responses. She talks about what we can learn from mouse models and the role of PTPN22 in antiviral immunity. 
1h 10m
Sep 23
Ep. 115: “Intercellular Communication” Featuring Dr. Harikesh Wong
Dr. Harikesh Wong is an Assistant Professor at the Ragon Institute and MIT, where his lab studies the design principles of the immune system. He talks about how Tregs constrain conventional T cell responses during infection, and advanced fluorescence microscopy techniques to stud ... Show More
1h 11m
Sep 9
Ep. 114: “The Importance of Investing in Science” Featuring Dr. Eric Vivier
Dr. Eric Vivier is a Professor of Immunology at Aix-Marseille Université and the Centre d'Immunologie de Marseille-Luminy. He is also an awardee of the European Research Council and a member of the French Society of Immunology. In this special episode recorded at the IUIS 2025 Co ... Show More
1h 9m
Recommended Episodes
Jun 2025
Reprogramming Immunity: Unlocking CAR-NK Cells with Dr. Hind Rafei
In this episode, Dr. Hind Rafei dives into the cutting-edge world of CAR-NK cell therapy and its potential to revolutionize cancer treatment. Unlike their T-cell counterparts, CAR-NK cells promise enhanced safety and innate tumor-killing ability. But what if their power could be ... Show More
26m 51s
Oct 2017
Immune 1: Some like it hot
Cindy, Steph, and Vincent launch a new podcast, Immune, and reveal how warm temperature protects against atherosclerosis by regulating monocyte migration into the blood. Hosts: Vincent Racaniello, Stephanie Langel, and Cynthia Leifer Become a patron of Immune! Links for this epis ... Show More
1h 5m
Aug 2024
The Effect of Histone Demethylases on Gene Expression and Cancer Cell Stability (Johnathan Whetstine)
In this episode of the Epigenetics Podcast, we talked with Johnathan Whetstine from Fox Chase Cancer Center about his work on how histone demethylases affect gene expression and cancer cell stability. The Interview start by discussing a pivotal paper from Jonathan's lab in 2010, ... Show More
39m 37s
Jan 2025
Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cel
In this week's episode we’ll learn more about an experimental regimen for classical Hodgkin lymphoma that combines brentuximab vedotin, nivolumab, and chemotherapy; a possible role for type 1 interferon signaling in developing autoantibodies to red blood cells in sickle cell dise ... Show More
21m 35s
Jan 2025
The Interplay of Nutrition, Metabolic Pathways, and Epigenetic Regulation (Ferdinand von Meyenn)
In this episode of the Epigenetics Podcast, we talked with Ferdinand von Meyenn from ETH Zürich about his work on the interplay of nutrition, metabolic pathways, and epigenetic regulation. To start Dr. Meyenn recounts his pivotal research on DNA methylation in naive embryonic ste ... Show More
48m 5s
Sep 2024
Episode 200: Immune Checkpoint Inhibitors
We discuss a new class of medications, Immune Checkpoint Inhibitors, and their side effects. Hosts: Avir Mitra, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Immune_Checkpoint_Inhibitors.mp3 Download Leave a Comment Tags: Oncology Show Notes Ov ... Show More
13m 26s
Feb 2022
Episode 005: Heme Path Series Pt. 4 - Molecular Testing
Molecular Testing PearlsIn Part 4 of our Heme Path series, we thoroughly examine the details of molecular testing and how it relates to hematologic and oncologic malignancies I. Molecular Testing BasicsA. Provides a means of assessing patient’s genotypes, specifically at smaller ... Show More
30m 36s
Sep 2024
Immunology: Foundations and Frameworks
How do we survive in a complex environment filled with harmful organisms that thrive on colonizing us? Our heroic defender is the immune system, a network of organs and cell lines that exist with the mission of protecting the body from harm. While we often recognize the pathogen- ... Show More
27m 11s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s